Furosemide ‘Myths’ Discussed at HBPA Convention
Tom LaMarra
January 16, 2012
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Furosemide, known as Salix, will be discussed Jan. 14 during the National HBPA Medication Committee forum.
The respiratory system can be a major cause of poor performance or premature retirement from competition.
The University of Calgary assistant professor wrote two papers presented in the Kester News Hour.
Topics covered included pleuropneumonia, equine multinodular pulmonary fibrosis, and lower airway inflammation
Could your horse have a respiratory disease? Here’s how your vet will find out.
The presentation discussed evidence-based approaches to treating airway disease (such as heaves) in horses.
Evidence-based approaches to treatment of airway disease in horses such as heaves (recurrent airway obstruction or RAO) and inflammatory airway disease (IAD), with Dr. Laurent Couetil of Purdue University.
There is a decided split between trainers and breeders on the issue of race day furosemide in Thoroughbreds.
The meeting began with several presentations on furosemide and EIPH, the condition the medication treats.
The Race Day Medication Committee is debating whether therapeutic medications such as Salix should be banned.
The Rutgers ESC has added a virtual tour of their exercise physiology laboratory to their website.
The new regulations were prompted by increased use of the substance as a replacement for anabolic steroids.
Researchers review the characteristics and impact of epiglottic abnormalities in nonracehorses.
The recording of our Ask the Vet LIVE Q&A event on Avoiding Respiratory Problems in the Barn is now online!
A number of air quality factors in barns can make it harder for your horse to breathe, compromising his health and performance.
Stay on top of the most recent Horse Health news with
